HUE060400T2 - Liposzómákba kapszulázott triterpenoid gombaellenes szerek injektálható készítményei - Google Patents
Liposzómákba kapszulázott triterpenoid gombaellenes szerek injektálható készítményeiInfo
- Publication number
- HUE060400T2 HUE060400T2 HUE18834263A HUE18834263A HUE060400T2 HU E060400 T2 HUE060400 T2 HU E060400T2 HU E18834263 A HUE18834263 A HU E18834263A HU E18834263 A HUE18834263 A HU E18834263A HU E060400 T2 HUE060400 T2 HU E060400T2
- Authority
- HU
- Hungary
- Prior art keywords
- liposomes
- antifungal agents
- injectable preparations
- agents encapsulated
- triterpenoid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862612893P | 2018-01-02 | 2018-01-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE060400T2 true HUE060400T2 (hu) | 2023-02-28 |
Family
ID=65024141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE18834263A HUE060400T2 (hu) | 2018-01-02 | 2018-12-21 | Liposzómákba kapszulázott triterpenoid gombaellenes szerek injektálható készítményei |
Country Status (27)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7378401B2 (ja) * | 2018-01-02 | 2023-11-13 | サイネクシス,インコーポレーテッド | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| US7718189B2 (en) * | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
| NZ589967A (en) * | 2004-01-14 | 2012-07-27 | Gilead Sciences Inc | Lipid-based dispersions useful for drug delivery |
| ES2402659T3 (es) | 2006-04-03 | 2013-05-07 | Merck Sharp & Dohme Corp. | Derivados de enfumafungina como agentes antifúngicos |
| CA2700530C (en) * | 2007-09-28 | 2014-12-09 | Merck Sharp & Dohme Corp. | Antifungal agents |
| US8226965B2 (en) * | 2008-04-25 | 2012-07-24 | Nanobio Corporation | Methods of treating fungal, yeast and mold infections |
| JP2011529038A (ja) * | 2008-07-23 | 2011-12-01 | ターゲッティド デリバリー テクノロジーズ リミテッド | 真菌感染症の処置のための局所抗真菌製剤の投与方法 |
| WO2010019204A1 (en) * | 2008-08-12 | 2010-02-18 | Merck Sharp & Dohme Corp. | Antifungal agents |
| PE20120923A1 (es) * | 2009-03-30 | 2012-08-27 | Eisai Randd Man Co Ltd | Composiciones farmaceuticas comprendiendo liposomas que contiene eribulina o una sal del mismo |
| PT3247711T (pt) * | 2015-01-19 | 2022-05-16 | Scynexis Inc | Novos sais e polimorfos de scy-078 |
| JP7378401B2 (ja) * | 2018-01-02 | 2023-11-13 | サイネクシス,インコーポレーテッド | リポソームの中にカプセル化されたトリテルペノイド抗真菌薬の注射可能な組成物 |
-
2018
- 2018-12-21 JP JP2020536766A patent/JP7378401B2/ja active Active
- 2018-12-21 SI SI201830746T patent/SI3735226T1/sl unknown
- 2018-12-21 CN CN202310046755.4A patent/CN115998684A/zh active Pending
- 2018-12-21 SG SG11202006313WA patent/SG11202006313WA/en unknown
- 2018-12-21 HU HUE18834263A patent/HUE060400T2/hu unknown
- 2018-12-21 SM SM20220427T patent/SMT202200427T1/it unknown
- 2018-12-21 US US16/958,691 patent/US20200338002A1/en not_active Abandoned
- 2018-12-21 EP EP22187779.8A patent/EP4137123A1/en active Pending
- 2018-12-21 AU AU2018399599A patent/AU2018399599B2/en active Active
- 2018-12-21 IL IL275758A patent/IL275758B2/en unknown
- 2018-12-21 HR HRP20221295TT patent/HRP20221295T1/hr unknown
- 2018-12-21 IL IL318793A patent/IL318793A/en unknown
- 2018-12-21 RS RS20220981A patent/RS63687B1/sr unknown
- 2018-12-21 EP EP18834263.8A patent/EP3735226B1/en active Active
- 2018-12-21 PT PT188342638T patent/PT3735226T/pt unknown
- 2018-12-21 PL PL18834263.8T patent/PL3735226T3/pl unknown
- 2018-12-21 DK DK18834263.8T patent/DK3735226T3/da active
- 2018-12-21 CN CN201880087851.0A patent/CN111655237B/zh active Active
- 2018-12-21 CA CA3087176A patent/CA3087176A1/en active Pending
- 2018-12-21 ES ES18834263T patent/ES2927051T3/es active Active
- 2018-12-21 MA MA051514A patent/MA51514A/fr unknown
- 2018-12-21 WO PCT/US2018/067216 patent/WO2019135954A1/en not_active Ceased
- 2018-12-21 LT LTEPPCT/US2018/067216T patent/LT3735226T/lt unknown
- 2018-12-21 KR KR1020207022062A patent/KR102694692B1/ko active Active
- 2018-12-21 EA EA202091626A patent/EA202091626A1/ru unknown
- 2018-12-21 UA UAA202004935A patent/UA126096C2/uk unknown
- 2018-12-21 MD MDE20201148T patent/MD3735226T2/ro unknown
- 2018-12-21 MX MX2020006992A patent/MX2020006992A/es unknown
- 2018-12-27 TW TW107147395A patent/TWI857944B/zh active
- 2018-12-27 TW TW112144149A patent/TWI862280B/zh active
-
2020
- 2020-06-30 SA SA520412362A patent/SA520412362B1/ar unknown
-
2022
- 2022-10-04 US US17/960,076 patent/US20230277455A1/en not_active Abandoned
-
2023
- 2023-10-31 JP JP2023187032A patent/JP2024012452A/ja not_active Withdrawn
-
2024
- 2024-03-18 US US18/608,350 patent/US20250082574A1/en not_active Abandoned
-
2025
- 2025-04-01 JP JP2025060460A patent/JP2025106349A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284185A (en) | Compositions for drg-specific reduction of transgene expression | |
| DK4151637T3 (da) | Gadolinium-indeholdende pcta-baserede kontrastmidler | |
| IL292716A (en) | Pro-perfume compositions | |
| HRP20220269T8 (hr) | Heterociklilamino-supstituirani triazoli kao modulatori rho-povezane protein kinaze | |
| MA46696A (fr) | Formulations injectables à dose unique prêtes à l'emploi | |
| PL3603620T3 (pl) | Kompozycja liposomowa i kompozycja farmaceutyczna | |
| HUE057877T2 (hu) | Vegyületek és készítmények terápiás szerek intracelluláris bejuttatására | |
| MA41453A (fr) | Encapsulation d'agents actifs très puissants | |
| DK3548058T3 (da) | Sammensætninger omfattende peptid wkdeagkplvk | |
| EP3813234A4 (en) | FITTINGS | |
| HRP20192173T8 (hr) | Ekspresija rekombinantnih proteina u kukuljicama vrste trichoplusia ni | |
| DK3429689T3 (da) | Acellulære placentapræparater | |
| EP3340793C0 (fr) | Composition répulsive contre les insectes vecteurs de maladies tropicales sous forme de spray | |
| IT201600068623A1 (it) | “use of a lignin fraction as an anti-phytopathogenic agent and anti-phytopathogenic compositions comprising the same” / “uso di una frazione di lignina come agente antifitopatogenico e composizioni antifitopatogeniche che la comprendono” | |
| IL263714A (en) | Depot formulations | |
| IL270949A (en) | Protease and binding polypeptide for o-glycoproteins | |
| IL283627A (en) | Improved transport of large materials | |
| EP3960152A4 (en) | COSMETIC PREPARATIONS | |
| IL292092A (en) | Insecticidal mixtures of bifenthrin and chlorantraniliprole | |
| EP3651786C0 (en) | ANTIMICROBIAL PEPTIDES AGAINST LISTERIA MONOCYTOGENES | |
| DK3600435T3 (da) | Højeffektiv indkapsling af hydrofile forbindelser i unilamellære liposomer | |
| EP3578566C0 (en) | BIOCIDAL PEPTIDE AND MEDICINAL PREPARATION ON THIS BASIS | |
| LT3582617T (lt) | Pesticidinių piridazinpirazolamidų stabili kompozicija | |
| EP3432730C0 (de) | Mehrphasige wirkstoffzubereitungen | |
| LT3735226T (lt) | Triterpenoidų priešgrybelinių agentų, įkapsuliuotų liposomose, injekuojamos kompozicijos |